Crozil Life Sciences (Opc) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
About Crozil Life Sciences (Opc)
Crozil Life Sciences (Opc) Private Limited (CLSOPL) is a Company incorporated in India on 30 November 2017 (Seven years and two months 3 days old ). Its registered office is in Faridabad, Haryana, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vikas Kaushik and Rakesh Vasisht serve as directors at the Company.
Company Details
-
Location
Faridabad, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999HR2017OPC071664
-
Company No.
071664
-
Incorporation Date
30 Nov 2017
-
Date of AGM
24 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Crozil Life Sciences (Opc) Private Limited offer?
Crozil Life Sciences (Opc) Private Limited offers a wide range of products and services, including Antipyretic Medication, Paracetamol Tablets.
Who are the key members and board of directors at Crozil Life Sciences (Opc)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Kaushik
|
Director | 30-Nov-2017 | Current |
|
Rakesh Vasisht
|
Director | 16-Mar-2018 | Current |
Financial Performance of Crozil Life Sciences (Opc).
Enhance accessibility to Crozil Life Sciences (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crozil Life Sciences (Opc)?
Unlock access to Crozil Life Sciences (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Human Excellence FoundationVikas Kaushik is a mutual person
-
Crozil Pharmaceuticals Private Limited
Rakesh Vasisht is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Crozil Life Sciences (Opc)?
Unlock and access historical data on people associated with Crozil Life Sciences (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crozil Life Sciences (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crozil Life Sciences (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.